Overall, our results demonstrate that the low levels of tumor-infiltrating CD8+ Teff cells are dominated by CD4+ and CD8+ Tregs in CRC tumors, which display activated phenotypes with immunosuppressive functions [18]. This evidence concerns the gene CD8A and colorectal carcinoma.